BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1965112)

  • 21. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
    Fox MP; Otto MJ; McKinlay MA
    Antimicrob Agents Chemother; 1986 Jul; 30(1):110-6. PubMed ID: 3019232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 1-(phenyl)-N'-(4-methoxybenzylidene)-9H-pyrido[3,4-b] indole-3-carbohydrazide on in vitro poliovirus replication.
    Santos PR; Formagio AS; Dias Filho BP; Nakamura CV; Sarragiotto MH; Ueda-Nakamura T
    Acta Pharm; 2015 Mar; 65(1):75-81. PubMed ID: 25781706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral activity and mechanism of action of 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (MDL-860).
    Torney HL; Dulworth JK; Steward DL
    Antimicrob Agents Chemother; 1982 Oct; 22(4):635-8. PubMed ID: 7181474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific inhibition of poliovirus induced blockade of cell protein synthesis by a thiopyrimidine derivative.
    La Colla P; Marcialis MA; Mereu GP; Loddo B
    J Gen Virol; 1972 Oct; 17(1):13-8. PubMed ID: 4343527
    [No Abstract]   [Full Text] [Related]  

  • 25. Irreversible impairment produced by guanidine on the functions of poliovirus proteins.
    Marcialis MA; Schivo ML; Cioglia AM; Atzeni A; Loddo B
    Experientia; 1973 Dec; 29(12):1561-3. PubMed ID: 4358961
    [No Abstract]   [Full Text] [Related]  

  • 26. The mechanism of guanidine inhibition of poliovirus growth in vitro.
    La Colla P; De Giuli C; Cioglia AM; Zuffardi O; Loddo B
    Life Sci II; 1970 Dec; 9(23):1351-8. PubMed ID: 4099578
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of poliovirus uncoating by disoxaril (WIN 51711).
    Zeichhardt H; Otto MJ; McKinlay MA; Willingmann P; Habermehl KO
    Virology; 1987 Sep; 160(1):281-5. PubMed ID: 2820136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus.
    Semple SJ; Pyke SM; Reynolds GD; Flower RL
    Antiviral Res; 2001 Mar; 49(3):169-78. PubMed ID: 11428243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 6-(3,4-Dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating.
    González ME; Almela MJ; Yacout M; Carrasco L
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1259-61. PubMed ID: 2168147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of poliovirus-specific RNA synthesis and the effects of inhibitors of virus replication.
    Noble J; Levintow L
    Virology; 1970 Mar; 40(3):634-42. PubMed ID: 4314509
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiviral effect of Guazuma ulmifolia and Stryphnodendron adstringens on poliovirus and bovine herpesvirus.
    Felipe AM; Rincão VP; Benati FJ; Linhares RE; Galina KJ; de Toledo CE; Lopes GC; de Mello JC; Nozawa C
    Biol Pharm Bull; 2006 Jun; 29(6):1092-5. PubMed ID: 16754999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antiviral activity of a saponin from Anagallis arvensis, Primulaceae, against herpes simplex virus and poliovirus.
    Amoros M; Fauconnier B; Girre RL
    Antiviral Res; 1987 Aug; 8(1):13-25. PubMed ID: 2825589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of phleomycin on poliovirus RNA replication.
    Hecht TT; Summers DF
    Virology; 1970 Mar; 40(3):441-7. PubMed ID: 4314502
    [No Abstract]   [Full Text] [Related]  

  • 34. Identification and Analysis of Antiviral Compounds Against Poliovirus.
    Leyssen P; Franco D; Tijsma A; Lacroix C; De Palma A; Neyts J
    Methods Mol Biol; 2016; 1387():325-38. PubMed ID: 26983743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poliovirus infection without accumulation of eclipse particles.
    Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
    Antiviral Res; 1995 Jan; 26(1):27-35. PubMed ID: 7741519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfated polysaccharide of Caesalpinia ferrea inhibits herpes simplex virus and poliovirus.
    Lopes N; Faccin-Galhardi LC; Espada SF; Pacheco AC; Ricardo NM; Linhares RE; Nozawa C
    Int J Biol Macromol; 2013 Sep; 60():93-9. PubMed ID: 23707733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The poliovirus-induced shut-off of cellular protein synthesis persists in the presence of 3-methylquercetin, a flavonoid which blocks viral protein and RNA synthesis.
    Vrijsen R; Everaert L; Van Hoof LM; Vlietinck AJ; Vanden Berghe DA; Boeyé A
    Antiviral Res; 1987 Jan; 7(1):35-42. PubMed ID: 3026245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of soluble cytokines on the restricted replication of poliovirus in the monocytic U937 cell line.
    López-Guerrero JA; Pimentel-Muiños FX; Fresno M; Alonso MA
    Virus Res; 1990 Jun; 16(2):225-30. PubMed ID: 2166982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Sindbis virus replication by cyclopentenone prostaglandins: a cell-mediated event associated with heat-shock protein synthesis.
    Mastromarino P; Conti C; Petruzziello R; De Marco A; Pica F; Santoro MG
    Antiviral Res; 1993 Mar; 20(3):209-22. PubMed ID: 8470883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of Poliovirus Resistance to Host Phosphatidylinositol-4 Kinase III β Inhibitor.
    Arita M
    ACS Infect Dis; 2016 Feb; 2(2):140-8. PubMed ID: 27624965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.